-
Something wrong with this record ?
In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
J. Janockova, J. Korabecny, J. Plsikova, K. Babkova, E. Konkolova, D. Kucerova, J. Vargova, J. Koval, R. Jendzelovsky, P. Fedorocko, J. Kasparkova, V. Brabec, J. Rosocha, O. Soukup, S. Hamulakova, K. Kuca, M. Kozurkova,
Language English Country England, Great Britain
Document type Journal Article
NLK
Directory of Open Access Journals
from 2017
PubMed Central
from 2017
Europe PubMed Central
from 2017 to 2020
Taylor & Francis Open Access
from 2002-01-01
Medline Complete (EBSCOhost)
from 2007-02-01
- MeSH
- A549 Cells MeSH
- Fibroblasts drug effects MeSH
- HL-60 Cells MeSH
- Humans MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemical synthesis chemistry pharmacology MeSH
- Drug Screening Assays, Antitumor MeSH
- Tacrine chemistry pharmacology MeSH
- Thiourea chemistry pharmacology MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
A combination of biochemical, biophysical and biological techniques was used to study calf thymus DNA interaction with newly synthesized 7-MEOTA-tacrine thiourea 12-17 and urea heterodimers 18-22, and to measure interference with type I and II topoisomerases. Their biological profile was also inspected in vitro on the HL-60 cell line using different flow cytometric techniques (cell cycle distribution, detection of mitochondrial membrane potential dissipation, and analysis of metabolic activity/viability). The compounds exhibited a profound inhibitory effect on topoisomerase activity (e.g. compound 22 inhibited type I topoisomerase at 1 µM concentration). The treatment of HL-60 cells with the studied compounds showed inhibition of cell growth especially with hybrids containing thiourea (14-17) and urea moieties (21 and 22). Moreover, treatment of human dermal fibroblasts with the studied compounds did not indicate significant cytotoxicity. The observed results suggest beneficial selectivity of the heterodimers as potential drugs to target cancer cells.
Associated Tissue Bank Faculty of Medicine P J Šafárik University Kosice Slovak Republic
b Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic
f Department of Biophysics Faculty of Science Palacke University Olomouc Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027677
- 003
- CZ-PrNML
- 005
- 20190823104643.0
- 007
- ta
- 008
- 190813s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/14756366.2019.1593159 $2 doi
- 035 __
- $a (PubMed)30938202
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Janockova, Jana $u a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic. b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
- 245 10
- $a In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers / $c J. Janockova, J. Korabecny, J. Plsikova, K. Babkova, E. Konkolova, D. Kucerova, J. Vargova, J. Koval, R. Jendzelovsky, P. Fedorocko, J. Kasparkova, V. Brabec, J. Rosocha, O. Soukup, S. Hamulakova, K. Kuca, M. Kozurkova,
- 520 9_
- $a A combination of biochemical, biophysical and biological techniques was used to study calf thymus DNA interaction with newly synthesized 7-MEOTA-tacrine thiourea 12-17 and urea heterodimers 18-22, and to measure interference with type I and II topoisomerases. Their biological profile was also inspected in vitro on the HL-60 cell line using different flow cytometric techniques (cell cycle distribution, detection of mitochondrial membrane potential dissipation, and analysis of metabolic activity/viability). The compounds exhibited a profound inhibitory effect on topoisomerase activity (e.g. compound 22 inhibited type I topoisomerase at 1 µM concentration). The treatment of HL-60 cells with the studied compounds showed inhibition of cell growth especially with hybrids containing thiourea (14-17) and urea moieties (21 and 22). Moreover, treatment of human dermal fibroblasts with the studied compounds did not indicate significant cytotoxicity. The observed results suggest beneficial selectivity of the heterodimers as potential drugs to target cancer cells.
- 650 _2
- $a buňky A549 $7 D000072283
- 650 _2
- $a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a fibroblasty $x účinky léků $7 D005347
- 650 _2
- $a HL-60 buňky $7 D018922
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a takrin $x chemie $x farmakologie $7 D013619
- 650 _2
- $a thiomočovina $x chemie $x farmakologie $7 D013890
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Korabecny, Jan $u b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Plsikova, Jana $u a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic. d Associated Tissue Bank, Faculty of Medicine , P.J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Babkova, Katerina $u b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Konkolova, Eva $u a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Kucerova, Dana $u e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Vargova, Jana $u e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Koval, Jan $u e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Jendzelovsky, Rastislav $u e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Fedorocko, Peter $u e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Kasparkova, Jana $u f Department of Biophysics, Faculty of Science , Palacke University , Olomouc , Czech Republic.
- 700 1_
- $a Brabec, Viktor $u f Department of Biophysics, Faculty of Science , Palacke University , Olomouc , Czech Republic.
- 700 1_
- $a Rosocha, Jan $u d Associated Tissue Bank, Faculty of Medicine , P.J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Soukup, Ondrej $u b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic. c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Hamulakova, Slavka $u g Department of Organic Chemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
- 700 1_
- $a Kuca, Kamil $u b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
- 700 1_
- $a Kozurkova, Maria $u a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic. b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
- 773 0_
- $w MED00008009 $t Journal of enzyme inhibition and medicinal chemistry $x 1475-6374 $g Roč. 34, č. 1 (2019), s. 877-897
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30938202 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823104857 $b ABA008
- 999 __
- $a ok $b bmc $g 1432826 $s 1066137
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 34 $c 1 $d 877-897 $e - $i 1475-6374 $m Journal of enzyme inhibition and medicinal chemistry $n J Enzyme Inhib Med Chem $x MED00008009
- LZP __
- $a Pubmed-20190813